Our study helps define the mutational spectrum in breast cancer patients suggestive of LFS, contributes to a potential relevance of CDKN2A/p14ARF in LFS/LFL settings, and points out the need for intensified research on monoallelic variants in Fanconi pathway and RECQ family genes. The gene discussed is CDKN2A; the disease is breast cancer.